Dr. Leena T. Rahmat is a hematologist/oncologist specializing in the management of hematologic malignancies with a focus on lymphoma. She is double boarded in both hematology and oncology. Dr. Rahmat received her medical degree with honors from the Royal College of Surgeons in Ireland (RCSI) followed by a Master of Art in Clinical Investigation from Boston University School of Medicine (BUSM). She subsequently completed a residency in Internal Medicine and fellowships in both Hematology and Oncology at the University of Massachusetts Medical School-Baystate Medical Center. She went on to complete an advanced fellowship in Bone Marrow Transplantation and Hematologic Malignancies at the University of San Francisco (UCSF).
She has given international lectures and presentations on the treatment of blood cancers and is widely published in the field. Her clinical expertise includes lymphoproliferative disorders including non-Hodgkins lymphoma, Hodgkins lymphoma, Waldenstrom’s macroglobulinemia, chronic lymphocytic leukemia, and hematopoietic stem cell transplantation. Dr. Rahmat’s research interests include developing novel therapies for non-Hodgkins lymphoma, with a particular interest in predicting disease relapse, early disease interventions and the use of natural health products in the treatment of hematologic malignancies.
As a member of the Johns Hopkins Kimmel Cancer Center team in the Greater Washington Area, Dr. Rahmat is dedicated to the practice of precision medicine, using novel therapies including immunotherapy as medium to improve patients’ quality of life and outcomes.